Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

504 public trials 140 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

Study to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination With Rituximab in Participants With Relapsed and/or Refractory DLBCL and Other Forms of NHL

NCT02564744

Conditions
B-cell Non-Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Carle Foundation Hospital, Cancer Center Urbana, Illinois, United States
  • Abbott Northwestern Hospital, Virginia Piper Cancer Institute Minneapolis, Minnesota, United States
  • Novant Health Oncology Winston-Salem, North Carolina, United States
View all 39 locations
View Trial Details
Completed

Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies

NCT03424603

Conditions
B Cells--Tumors, B-cell Lymphoma, Blood Protein Disorders, +26 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Oncology Associates, PC--HOPE Division Tucson, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
View all 22 locations
View Trial Details
Completed

A Study of CC-97540, CD19-targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT04231747

Conditions
Agressive Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Diffuse-large B-cell Lymphoma (DLBCL), +13 more
Locations
  • Local Institution - 003 Birmingham, Alabama, United States
  • Local Institution - 004 Atlanta, Georgia, United States
  • Local Institution - 011 Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 14 locations
View Trial Details
Completed

A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma

NCT00457782

Conditions
B-cell Non-Hodgkin's Lymphoma, Blood Protein Disorders, Bronchial Diseases, +31 more
Locations
  • St Bartholomew's Hospital London, United Kingdom
  • UCLH London, United Kingdom
  • Christie Hospital Manchester, United Kingdom
  • Nottingham University NHS Trust Nottingham, United Kingdom
View Trial Details
Completed

Study of TG-1801 in Subjects With B-Cell Lymphoma

NCT03804996

Conditions
B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +12 more
Locations
  • TG Therapeutics Investigational Trial Site Heidelberg, Victoria, Australia
  • TG Therapeutics Investigational Trial Site Melbourne, Victoria, Australia
  • TG Therapeutics Investigational Trial Site Nedlands, Western Australia, Australia
View Trial Details
Completed

Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL

NCT01897571

Conditions
Advanced Solid Tumors (Phase 1), B-cell Lymphomas (Phase 1), Diffuse Large B-cell Lymphoma (Phase 2), +15 more
Locations
  • Birmingham, Alabama, United States
  • Duarte, California, United States
  • Santa Barbara, California, United States
  • Aurora, Colorado, United States
View all 52 locations
View Trial Details
Completed

A Study Evaluating the Safety and Efficacy of Glofitamab or Mosunetuzumab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and High-Grade Large B-Cell Lymphoma

NCT04313608

Conditions
B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Prince of Wales Hospital; Haematology Randwick, New South Wales, Australia
  • Monash Health Monash Medical Centre Clayton, Victoria, Australia
  • St Vincent's Hospital Melbourne Fitzroy, Victoria, Australia
View Trial Details

Related conditions